EMEA Radiopharmaceutical Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Publisher Name :
Date: 12-Sep-2017
No. of pages: 120

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:

This report focuses on the Radiopharmaceutical in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  • Bayer

  • Triad Isotopes

  • Lantheus

  • GE Healthcare

  • Mallinckrodt

  • Eli Lilly

  • Bracco Imaging

  • SIEMENS

  • Navidea

  • Nordion

  • IBA Group

  • Jubilant Pharma

Market Segment by Regions, regional analysis covers

  • Europe (Germany, France, UK, Russia, Italy and Turkey)

  • Middle East (Saudi Arabia, Israel, UAE and Iran)

  • Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

  • Diagnostic Radioisotopes

  • Therapeutic Radioisotopes

Market Segment by Applications, can be divided into

  • Oncology

  • Cardiology

  • Other

There are 13 Chapters to deeply display the EMEA Radiopharmaceutical market.

Chapter 1, to describe Radiopharmaceutical Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Radiopharmaceutical, with sales, revenue, and price of Radiopharmaceutical, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Radiopharmaceutical, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Radiopharmaceutical research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

EMEA Radiopharmaceutical Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Table of Contents

1 Market Overview
1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 Diagnostic Radioisotopes
1.2.2 Therapeutic Radioisotopes
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
1.4.1.1 Germany Market States and Outlook (2012-2022)
1.4.1.2 France Market States and Outlook (2012-2022)
1.4.1.3 UK Market States and Outlook (2012-2022)
1.4.1.4 Italy Market States and Outlook (2012-2022)
1.4.1.5 Russia Market States and Outlook (2012-2022)
1.4.1.6 Turkey Market States and Outlook (2012-2022)
1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
1.4.2.2 UAE Market States and Outlook (2012-2022)
1.4.2.3 Israel Market States and Outlook (2012-2022)
1.4.2.4 Iran Market States and Outlook (2012-2022)
1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
1.4.3.1 South Africa Market States and Outlook (2012-2022)
1.4.3.2 Nigeria Market States and Outlook (2012-2022)
1.4.3.3 Egypt Market States and Outlook (2012-2022)
1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Radiopharmaceutical Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Triad Isotopes
2.2.1 Business Overview
2.2.2 Radiopharmaceutical Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Lantheus
2.3.1 Business Overview
2.3.2 Radiopharmaceutical Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GE Healthcare
2.4.1 Business Overview
2.4.2 Radiopharmaceutical Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mallinckrodt
2.5.1 Business Overview
2.5.2 Radiopharmaceutical Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Radiopharmaceutical Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bracco Imaging
2.7.1 Business Overview
2.7.2 Radiopharmaceutical Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 SIEMENS
2.8.1 Business Overview
2.8.2 Radiopharmaceutical Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Navidea
2.9.1 Business Overview
2.9.2 Radiopharmaceutical Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Nordion
2.10.1 Business Overview
2.10.2 Radiopharmaceutical Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 IBA Group
2.11.1 Business Overview
2.11.2 Radiopharmaceutical Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Jubilant Pharma
2.12.1 Business Overview
2.12.2 Radiopharmaceutical Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA Radiopharmaceutical Market Competition, by Manufacturer
3.1 EMEA Radiopharmaceutical Sales and Market Share by Manufacturer
3.2 EMEA Radiopharmaceutical Revenue and Market Share by Manufacturer
3.3 EMEA Radiopharmaceutical Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceutical Manufacturer Market Share
3.4.2 Top 5 Radiopharmaceutical Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA Radiopharmaceutical Market Analysis by Regions
4.1 EMEA Radiopharmaceutical Sales, Revenue and Market Share by Regions
4.1.1 EMEA Radiopharmaceutical Sales by Regions (2012-2017)
4.1.2 EMEA Radiopharmaceutical Revenue by Regions (2012-2017)
4.2 Europe Radiopharmaceutical Sales and Growth (2012-2017)
4.3 Middle East Radiopharmaceutical Sales and Growth (2012-2017)
4.4 Africa Radiopharmaceutical Sales and Growth (2012-2017)

5 Europe Radiopharmaceutical by Countries, Type, Application and Manufacturers
5.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Countries
5.1.1 Europe Radiopharmaceutical Sales by Countries (2012-2017)
5.1.2 Europe Radiopharmaceutical Revenue by Countries (2012-2017)
5.1.3 Germany Radiopharmaceutical Sales and Growth (2012-2017)
5.1.4 France Radiopharmaceutical Sales and Growth (2012-2017)
5.1.5 UK Radiopharmaceutical Sales and Growth (2012-2017)
5.1.6 Russia Radiopharmaceutical Sales and Growth (2012-2017)
5.1.7 Italy Radiopharmaceutical Sales and Growth (2012-2017)
5.1.8 Turkey Radiopharmaceutical Sales and Growth (2012-2017)
5.2 Europe Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
5.2.1 Europe Radiopharmaceutical Sales by Manufacturers (2016-2017)
5.2.2 Europe Radiopharmaceutical Revenue by Manufacturers (2016-2017)
5.3 Europe Radiopharmaceutical Sales by Type (2012-2017)
5.4 Europe Radiopharmaceutical Sales by Application (2012-2017)

6 Middle East Radiopharmaceutical by Countries, Type, Application and Manufacturers
6.1 Middle East Radiopharmaceutical Sales, Revenue and Market Share by Countries
6.1.1 Middle East Radiopharmaceutical Sales by Countries (2012-2017)
6.1.2 Middle East Radiopharmaceutical Revenue by Countries (2012-2017)
6.1.3 Saudi Arabia Radiopharmaceutical Sales and Growth (2012-2017)
6.1.4 Israel Radiopharmaceutical Sales and Growth (2012-2017)
6.1.5 UAE Radiopharmaceutical Sales and Growth (2012-2017)
6.1.6 Iran Radiopharmaceutical Sales and Growth (2012-2017)
6.2 Middle East Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
6.2.1 Middle East Radiopharmaceutical Sales by Manufacturers (2016-2017)
6.2.2 Middle East Radiopharmaceutical Revenue by Manufacturers (2016-2017)
6.3 Middle East Radiopharmaceutical Sales by Type (2012-2017)
6.4 Middle East Radiopharmaceutical Sales by Application (2012-2017)

7 Africa Radiopharmaceutical by Countries, Type, Application and Manufacturers
7.1 Africa Radiopharmaceutical Sales, Revenue and Market Share by Countries
7.1.1 Africa Radiopharmaceutical Sales by Countries (2012-2017)
7.1.2 Africa Radiopharmaceutical Revenue by Countries (2012-2017)
7.1.3 South Africa Radiopharmaceutical Sales and Growth (2012-2017)
7.1.4 Nigeria Radiopharmaceutical Sales and Growth (2012-2017)
7.1.5 Egypt Radiopharmaceutical Sales and Growth (2012-2017)
7.1.6 Algeria Radiopharmaceutical Sales and Growth (2012-2017)
7.2 Middle East Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
7.2.1 Middle East Radiopharmaceutical Sales by Manufacturers (2016-2017)
7.2.2 Middle East Radiopharmaceutical Revenue by Manufacturers (2016-2017)
7.3 Middle East Radiopharmaceutical Sales by Type (2012-2017)
7.4 Middle East Radiopharmaceutical Sales by Application (2012-2017)

8 EMEA Radiopharmaceutical Market Segment by Type
8.1 EMEA Radiopharmaceutical Sales, Revenue and Market Share by Type (2012-2017)
8.1.1 EMEA Radiopharmaceutical Sales and Market Share by Type (2012-2017)
8.1.2 EMEA Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
8.2 Diagnostic Radioisotopes Sales Growth and Price
10.2.1 EMEA Diagnostic Radioisotopes Sales Growth (2012-2017)
10.2.2 EMEA Diagnostic Radioisotopes Price (2012-2017)
8.3 Therapeutic Radioisotopes Sales Growth and Price
10.3.1 EMEA Therapeutic Radioisotopes Sales Growth (2012-2017)
10.3.2 EMEA Therapeutic Radioisotopes Price (2012-2017)

9 EMEA Radiopharmaceutical Market Segment by Application
9.1 EMEA Radiopharmaceutical Sales Market Share by Application (2012-2017)
9.2 Oncology Sales Growth (2012-2017)
9.3 Cardiology Sales Growth (2012-2017)
9.4 Other Sales Growth (2012-2017)

10 EMEA Radiopharmaceutical Market Forecast (2017-2022)
10.1 EMEA Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)
10.2 Radiopharmaceutical Market Forecast by Regions (2017-2022)
10.2.1 Europe Radiopharmaceutical Market Forecast by Regions (2017-2022)
10.2.1.1 Germany Radiopharmaceutical Sales Forecast 2017-2022
10.2.1.2 France Radiopharmaceutical Sales Forecast 2017-2022
10.2.1.3 UK Radiopharmaceutical Sales Forecast 2017-2022
10.2.1.4 Russia Radiopharmaceutical Sales Forecast 2017-2022
10.2.1.5 Italy Radiopharmaceutical Sales Forecast 2017-2022
10.2.1.6 Turkey Radiopharmaceutical Sales Forecast 2017-2022
10.2.2 Middle East Market Forecast by Regions (2017-2022)
10.2.2.1 Saudi Arabia Radiopharmaceutical Sales Forecast 2017-2022
10.2.2.2 Israel Radiopharmaceutical Sales Forecast 2017-2022
10.2.2.3 UAE Radiopharmaceutical Sales Forecast 2017-2022
10.2.2.4 Iran Radiopharmaceutical Sales Forecast 2017-2022
10.2.3 Africa Market Forecast by Regions (2017-2022)
10.2.3.1 South Africa Radiopharmaceutical Sales Forecast 2017-2022
10.2.3.2 Nigeria Radiopharmaceutical Sales Forecast 2017-2022
10.2.3.3 Egypt Radiopharmaceutical Sales Forecast 2017-2022
10.2.3.4 Algeria Radiopharmaceutical Sales Forecast 2017-2022
10.3 Radiopharmaceutical Market Forecast by Type (2017-2022)
10.4 Radiopharmaceutical Market Forecast by Application (2017-2022)

11 Sales Channel, Distributors, Traders and Dealers
11.1 Sales Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List of Tables and Figures

Figure Radiopharmaceutical Picture
Table Product Specifications of Radiopharmaceutical
Figure EMEA Sales Market Share of Radiopharmaceutical by Types in 2016
Table Radiopharmaceutical Types for Major Manufacturers
Figure Diagnostic Radioisotopes Picture
Figure Therapeutic Radioisotopes Picture
Table Radiopharmaceutical Sales Market Share by Applications in 2016
Figure Oncology Picture
Figure Cardiology Picture
Figure Other Picture
Figure Germany Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure France Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure UK Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Radiopharmaceutical Revenue (Value) and Growth Rate (2012-2022)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Radiopharmaceutical Type and Applications
Table Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table Triad Isotopes Radiopharmaceutical Type and Applications
Table Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lantheus Basic Information, Manufacturing Base and Competitors
Table Lantheus Radiopharmaceutical Type and Applications
Table Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Radiopharmaceutical Type and Applications
Table GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table Mallinckrodt Radiopharmaceutical Type and Applications
Table Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Radiopharmaceutical Type and Applications
Table Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table Bracco Imaging Radiopharmaceutical Type and Applications
Table Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SIEMENS Basic Information, Manufacturing Base and Competitors
Table SIEMENS Radiopharmaceutical Type and Applications
Table SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Navidea Basic Information, Manufacturing Base and Competitors
Table Navidea Radiopharmaceutical Type and Applications
Table Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nordion Basic Information, Manufacturing Base and Competitors
Table Nordion Radiopharmaceutical Type and Applications
Table Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table IBA Group Basic Information, Manufacturing Base and Competitors
Table IBA Group Radiopharmaceutical Type and Applications
Table IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table Jubilant Pharma Radiopharmaceutical Type and Applications
Table Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Radiopharmaceutical Sales by Manufacturer (2016-2017)
Figure EMEA Radiopharmaceutical Sales Market Share by Manufacturer in 2016
Figure EMEA Radiopharmaceutical Sales Market Share by Manufacturer in 2017
Table EMEA Radiopharmaceutical Revenue by Manufacturer (2016-2017)
Figure EMEA Radiopharmaceutical Revenue Market Share by Manufacturer in 2016
Figure EMEA Radiopharmaceutical Revenue Market Share by Manufacturer in 2017
Table EMEA Radiopharmaceutical Price by Manufacturer (2016-2017)
Figure EMEA Radiopharmaceutical Sales and Growth (2012-2017)
Figure EMEA Radiopharmaceutical Revenue and Growth (2012-2017)
Table EMEA Radiopharmaceutical Sales by Regions (2012-2017)
Table EMEA Radiopharmaceutical Sales Market Share by Regions (2012-2017)
Figure EMEA Radiopharmaceutical Sales Market Share by Regions in 2012
Figure EMEA Radiopharmaceutical Sales Market Share by Regions in 2016
Table EMEA Radiopharmaceutical Revenue by Regions (2012-2017)
Table EMEA Radiopharmaceutical Revenue Market Share by Regions (2012-2017)
Figure EMEA Radiopharmaceutical Revenue Market Share by Regions in 2012
Figure EMEA Radiopharmaceutical Revenue Market Share by Regions in 2016
Figure Europe Radiopharmaceutical Sales and Growth (2012-2017)
Figure Middle East Radiopharmaceutical Sales and Growth (2012-2017)
Figure Africa Radiopharmaceutical Sales and Growth (2012-2017)
Figure Europe Radiopharmaceutical Revenue and Growth (2012-2017)
Table Europe Radiopharmaceutical Sales by Countries (2012-2017)
Table Europe Radiopharmaceutical Sales Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceutical Sales Market Share by Countries in 2012
Figure Europe Radiopharmaceutical Sales Market Share by Countries in 2016
Table Europe Radiopharmaceutical Revenue by Countries (2012-2017)
Table Europe Radiopharmaceutical Revenue Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceutical Revenue Market Share by Countries in 2012
Figure Europe Radiopharmaceutical Revenue Market Share by Countries in 2016
Figure Germany Radiopharmaceutical Sales and Growth (2012-2017)
Figure France Radiopharmaceutical Sales and Growth (2012-2017)
Figure UK Radiopharmaceutical Sales and Growth (2012-2017)
Figure Russia Radiopharmaceutical Sales and Growth (2012-2017)
Figure Italy Radiopharmaceutical Sales and Growth (2012-2017)
Figure Turkey Radiopharmaceutical Sales and Growth (2012-2017)
Table Europe Radiopharmaceutical Sales by Manufacturer (2016-2017)
Figure Europe Radiopharmaceutical Sales Market Share by Manufacturer in 2016
Figure Europe Radiopharmaceutical Sales Market Share by Manufacturer in 2017
Table Europe Radiopharmaceutical Revenue by Manufacturer (2016-2017)
Figure Europe Radiopharmaceutical Revenue Market Share by Manufacturer in 2016
Figure Europe Radiopharmaceutical Revenue Market Share by Manufacturer in 2017
Table Europe Radiopharmaceutical Sales by Type (2012-2017)
Table Europe Radiopharmaceutical Sales Share by Type (2012-2017)
Table Europe Radiopharmaceutical Sales by Application (2012-2017)
Table Europe Radiopharmaceutical Sales Share by Application (2012-2017)
Figure Middle East Radiopharmaceutical Revenue and Growth (2012-2017)
Table Middle East Radiopharmaceutical Sales by Countries (2012-2017)
Table Middle East Radiopharmaceutical Sales Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceutical Sales Market Share by Countries in 2012
Figure Middle East Radiopharmaceutical Sales Market Share by Countries in 2016
Table Middle East Radiopharmaceutical Revenue by Countries (2012-2017)
Table Middle East Radiopharmaceutical Revenue Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceutical Revenue Market Share by Countries in 2012
Figure Middle East Radiopharmaceutical Revenue Market Share by Countries in 2016
Figure Saudi Arabia Radiopharmaceutical Sales and Growth (2012-2017)
Figure Israel Radiopharmaceutical Sales and Growth (2012-2017)
Figure UAE Radiopharmaceutical Sales and Growth (2012-2017)
Figure Iran Radiopharmaceutical Sales and Growth (2012-2017)
Table Middle East Radiopharmaceutical Sales by Manufacturer (2016-2017)
Figure Middle East Radiopharmaceutical Sales Market Share by Manufacturer in 2016
Figure Middle East Radiopharmaceutical Sales Market Share by Manufacturer in 2017
Table Middle East Radiopharmaceutical Revenue by Manufacturer (2016-2017)
Figure Middle East Radiopharmaceutical Revenue Market Share by Manufacturer in 2016
Figure Middle East Radiopharmaceutical Revenue Market Share by Manufacturer in 2017
Table Middle East Radiopharmaceutical Sales by Type (2012-2017)
Table Middle East Radiopharmaceutical Sales Share by Type (2012-2017)
Table Middle East Radiopharmaceutical Sales by Application (2012-2017)
Table Middle East Radiopharmaceutical Sales Share by Application (2012-2017)
Figure Africa Radiopharmaceutical Revenue and Growth (2012-2017)
Table Africa Radiopharmaceutical Sales by Countries (2012-2017)
Table Africa Radiopharmaceutical Sales Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceutical Sales Market Share by Countries in 2012
Figure Africa Radiopharmaceutical Sales Market Share by Countries in 2016
Table Africa Radiopharmaceutical Revenue by Countries (2012-2017)
Table Africa Radiopharmaceutical Revenue Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceutical Revenue Market Share by Countries in 2012
Figure Africa Radiopharmaceutical Revenue Market Share by Countries in 2016
Figure South Africa Radiopharmaceutical Sales and Growth (2012-2017)
Figure Nigeria Radiopharmaceutical Sales and Growth (2012-2017)
Figure Egypt Radiopharmaceutical Sales and Growth (2012-2017)
Figure Algeria Radiopharmaceutical Sales and Growth (2012-2017)
Table Middle East Radiopharmaceutical Sales by Manufacturer (2016-2017)
Figure Middle East Radiopharmaceutical Sales Market Share by Manufacturer in 2016
Figure Middle East Radiopharmaceutical Sales Market Share by Manufacturer in 2017
Table Middle East Radiopharmaceutical Revenue by Manufacturer (2016-2017)
Figure Middle East Radiopharmaceutical Revenue Market Share by Manufacturer in 2016
Figure Middle East Radiopharmaceutical Revenue Market Share by Manufacturer in 2017
Table Middle East Radiopharmaceutical Sales by Type (2012-2017)
Table Middle East Radiopharmaceutical Sales Share by Type (2012-2017)
Table Middle East Radiopharmaceutical Sales by Application (2012-2017)
Table Middle East Radiopharmaceutical Sales Share by Application (2012-2017)
Table EMEA Radiopharmaceutical Sales by Type (2012-2017)
Table EMEA Radiopharmaceutical Sales Share by Type (2012-2017)
Table EMEA Radiopharmaceutical Revenue by Type (2012-2017)
Table EMEA Radiopharmaceutical Revenue Share by Type (2012-2017)
Figure EMEA Diagnostic Radioisotopes Sales Growth (2012-2017)
Figure EMEA Diagnostic Radioisotopes Price (2012-2017)
Figure EMEA Therapeutic Radioisotopes Sales Growth (2012-2017)
Figure EMEA Therapeutic Radioisotopes Price (2012-2017)
Table EMEA Radiopharmaceutical Sales by Application (2012-2017)
Table EMEA Radiopharmaceutical Sales Share by Application (2012-2017)
Figure EMEA Oncology Sales Growth (2012-2017)
Figure EMEA Cardiology Sales Growth (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Radiopharmaceutical Sales Forecast by Regions (2017-2022)
Table EMEA Radiopharmaceutical Market Share Forecast by Regions (2017-2022)
Table Europe Radiopharmaceutical Sales Forecast by Regions (2017-2022)
Figure Germany Radiopharmaceutical Sales Forecast 2017-2022
Figure France Radiopharmaceutical Sales Forecast 2017-2022
Figure UK Radiopharmaceutical Sales Forecast 2017-2022
Figure Russia Radiopharmaceutical Sales Forecast 2017-2022
Figure Italy Radiopharmaceutical Sales Forecast 2017-2022
Figure Turkey Radiopharmaceutical Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Radiopharmaceutical Sales Forecast 2017-2022
Figure Israel Radiopharmaceutical Sales Forecast 2017-2022
Figure UAE Radiopharmaceutical Sales Forecast 2017-2022
Figure Iran Radiopharmaceutical Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Radiopharmaceutical Sales Forecast 2017-2022
Figure Nigeria Radiopharmaceutical Sales Forecast 2017-2022
Figure Egypt Radiopharmaceutical Sales Forecast 2017-2022
Figure Algeria Radiopharmaceutical Sales Forecast 2017-2022
Table EMEA Radiopharmaceutical Sales Forecast by Type (2017-2022)
Table EMEA Radiopharmaceutical Market Share Forecast by Type (2017-2022)
Table EMEA Radiopharmaceutical Sales Forecast by Application (2017-2022)
Table EMEA Radiopharmaceutical Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List
  • Global Radiopharmaceutical Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jun-2018        Price: US 3480 Onwards        Pages: 147
    Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for ex......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Radiopharmaceutical Market 2018, Forecast to 2023
    Published: 20-Jun-2018        Price: US 4880 Onwards        Pages: 154
    Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for ex......
  • 2018-2023 Global Radiopharmaceuticals Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 158
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Radiopharmaceuticals market for 2018-2023. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioi......
  • 2018 Top 5 Radiopharmaceuticals Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 142
    Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for ex......
  • Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023
    Published: 14-Jun-2018        Price: US 5650 Onwards        Pages: 213
    “The nuclear medicine market is projected to grow at a CAGR of 5.9%” The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018. Factors such as the growing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99, are driving market growth. However, the short half-life of radiopharmaceuticals, hospital budget cuts, and high equipment prices are likely to......
  • Global Radiopharmaceutical Market Research Report 2018
    Published: 04-Jun-2018        Price: US 2900 Onwards        Pages: 108
    This report studies the global Radiopharmaceutical market status and forecast, categorizes the global Radiopharmaceutical market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is c......
  • Global Radiopharmaceuticals Market Research Report 2018
    Published: 01-Jun-2018        Price: US 2900 Onwards        Pages: 108
    This report studies the global Radiopharmaceuticals market status and forecast, categorizes the global Radiopharmaceuticals market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is......
  • Global Radiopharmaceuticals Market Professional Survey Report 2018
    Published: 29-May-2018        Price: US 3500 Onwards        Pages: 116
    This report studies the global Radiopharmaceuticals market status and forecast, categorizes the global Radiopharmaceuticals market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Radiopharmaceuticals market is valued at xx million US$ in 2017 and is expected to reach xx mi......
  • 2018 Top 5 Radiopharmaceutical Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 21-May-2018        Price: US 4960 Onwards        Pages: 110
    The Global Radiopharmaceutical market size will be XX million (USD) in 2023, from the XX million (USD) in 2017, with a CAGR (Compound Annual Growth Rate) of XX% from between 2017 and 2023. This report studies the global Radiopharmaceutical market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Radiopharmaceutical players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players inc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs